J. Safra Asset Management’s Akero Therapeutics AKRO Stock Holding History

J. Safra Asset Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-39	Closed	-$1.85K	–	626
2025 Q3	$1.85K	Hold	39	–	–	﹤0.01%	421
2025 Q2	$2.08K	Buy	+39	New	+$1.77K	﹤0.01%	348

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

J. Safra Asset Management's AKRO Position: Q4 2025 in Review

J. Safra Asset Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 39 shares — an estimated $1.85K sold.

J. Safra Asset Management first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $2.08K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

J. Safra Asset Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
J. Safra Asset Management sold 39 Akero Therapeutics shares in Q4 2025, an estimated $1.85K.
J. Safra Asset Management first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
J. Safra Asset Management's Akero Therapeutics position peaked at $2.08K in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on J. Safra Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.